Cardiovascular Systems posts Street-beating FY2019 Q2 earnings

January 30, 2019 By Fink Densford

Cardiovascular Systems (NSDQ:CSII) today posted fiscal year 2019 second quarter earnings that beat expectations on Wall Street.

The St. Paul, Minn.-based company posted profits of $492,000, or 1¢ per share, on sales of approximately $60.2 million for the three months ended December 31, seeing a swing from the red on the bottom line while sales grew 14.4% compared with the same period during the previous fiscal year.

Earnings per share for the quarter were ahead of the 1¢ loss consensus on Wall Street, where analysts were looking for sales of $59.7 million, which the company also topped.

“We are driving market leading performance with orbital atherectomy and we are executing on our key growth initiatives to introduce new products and launch our business in new markets around the world,” prez & CEO Scott Ward said in a press release.

Cardiovascular Systems updated its financial guidance, narrowing its full year sales guidance to between $243 million and $247 million from previous guidance of between $240 million and $250 million. The company said it expects to post a net loss equal to 1% to 2% of revenue, with gross profit as a percentage of revenue of approximately 80%.

“Revenues grew 13.8% during the first half of fiscal 2019. Our key revenue drivers came in on plan; domestic atherectomy grew 10% and we added $4.2 million in new revenue from international distributors and the domestic sale of OrbusNeich angioplasty balloons and Zilient guidewires. We anticipate similar contributions from these drivers during the second half of fiscal 2019. As a result, we remain on track to achieve the midpoint of our fiscal 2019 revenue guidance range. In conjunction with our pre-announcement of second quarter revenue results on January 7, we narrowed our fiscal 2019 revenue expectations to a range of $243 million to $247 million from a range of $240 million to $250 million. Our gross margin and profitability expectations for fiscal 2019 remain consistent with the financial guidance we provided at our analyst day meeting on July 31, 2018,” Ward said in a prepared statement.

Shares in Cardiovascular Systems rose approximately 3.4% today, closing at $30.06.

Earlier this month, Cardiovascular Systems said that it won approval from Japan’s Ministry of Health, Labor and Welfare for its Diamondback 360 coronary orbital atherectomy system and its Classic Crown and ViperWire Advance coronary guidewire FlexTip.

How SpaceX is helping Medtronic prepare for the next pandemic wave
As COVID-19 cases erupted around the globe earlier this year, Medtronic (NYSE:MDT) faced unprecedented demand for its ventilators. At first, Medtronic engineer Matt Phillips wasn’t sure how the company was going to supply enough ventilators to meet the surging global need. Then Elon Musk called with a proposal. Space Exploration Corporation (SpaceX), Elon Musk’s California-based company… […]
Could hydrogels and magnetic fields grow new cartilage?
Researchers at the University of Pennsylvania are touting a new way to potentially rebuild complex body tissues to fix common injuries like cartilage degeneration. Following the publication of research in Advanced Materials, those involved are suggesting that the rebuilding process for these body tissues could be done by using a magnetic field and hydrogels, according to… […]
U of M researchers receive $6.6M to develop neuromod device for mental health
Researchers at the University of Minnesota were last month awarded a $6.6 million grant to develop a device for treating mental health disorders. The National Institute of Mental Health provided the grant award in support of the development of a new medical device for treating those disorders by using brain rhythms, something that hasn’t been… […]
Stryker launches ‘smart’ hospital bed
Stryker today announced the global launch of the industry’s first and only completely wireless hospital bed, ProCuity. ProCuity was designed to help reduce in-hospital patient falls at all acuity levels, improve nurse workflow and safety, and help lower hospital costs, according to Kalamazoo, Mich.-based Stryker. It is the only bed on the market today that… […]
3M and Eko collaborate on stethoscopes
3M (NYSE:MMM) and Eko announced today that they are collaborating to combine 3M’s Littmann stethoscope with Eko’s digital innovations. St. Paul, Minn.-based 3M’s new Littmann CORE digital stethoscope includes capabilities for clinicians to access both analog and digital auscultation options, along with amplification and noise cancellation and the visualization of sound during auscultation. 3M and Oakland,… […]
Henkel, Carbon expand 3D-printing partnership
Henkel and Carbon today announced a partnership that will make Henkel’s single-component technologies immediately available to Carbon customers for use with Carbon’s additive manufacturing process. The agreement includes access to Henkel’s Loctite 3D IND405 clear resin, certified for Carbon’s Digital Light Synthesis (Carbon DLS) 3D-printing process. Loctite 3D IND405 may be used for enclosures and housings, light… […]
This surgeon developed an abdominal device to reduce hospital stays
Many doctors have visualized devices to solve medical problems. The founder and CEO of Noleus Technologies has devised one to address prolonged hospital stays after abdominal surgery. As a practicing surgeon specializing in surgical oncology, colon and rectal surgery, Dr. Swarna Balasubramaniam had an idea over 20 years ago that she thought could make surgeons’… […]
Supply chain tool IDs COVID-19 supply shortages
The American Society for Microbiology (ASM) has developed an online platform to identify COVID-19 and non-COVID testing supply shortages. In partnership with the Associaton for Supply Chain Management (ASCM), ASM developed the platform to identify and monitor the testing supplies to be made aware of shortages in real-time, according to a news release. Get the… […]
Saraca Solutions seeks to slash clinical evaluation report times
Saraca Solutions announced today that it has developed a tracking tool to reduce the time it takes to create an update for a clinical evaluation report (CER). A CER documents conclusions for a medical device’s clinical evaluation. It consists of analyzed clinical data collected from either investigation of a company’s device or studies of substantially… […]
These small companies are making big COVID-19 contributions
Major companies continue grabbing the headlines around the COVID-19 pandemic, but smaller companies have contributed their share toward helping patients, boosting research and keeping frontline workers safe. This week, Minnesota’s Medical Alley Association issued a report on its members’ pandemic responses, including companies large and small, from telehealth providers to a tube-feeding company. We wanted… […]
Schurter adds switch for harsh environments
Schurter recently debuted a piezoelectric switch, PSE, which is installation-ready with its pre-assembled 15-meter-long cable. The potted polyurethane cable offers installation flexibility with the highest IP67 protection according to IEC 60529 and IP69K according to DIN 40050-9, according to the company. Designed to be waterproof from its surface to its electrical connections the switch’s housing… […]